drugset / Trial / NCT03133975

Vitamin D Supplementation for Treatment of Dyslipidemia

NCT03133975

Phase 3 Unknown 30 enrolled Mansoura University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will be conducted to Assess possible reduction in lipid profile (LDL-Triglecerides-cholesterol) among pre-menopausal women in vit D group compared to standard treatment group after 3 months \& 6 month of follow up as prophylaxis step for atherosclerosis.

Timeline

Start
2017-04-01
Primary completion
2018-12-31
Completion
2019-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified Intramuscular

Indications